Outcomes of patients with metastatic cutaneous squamous cell carcinoma to the axilla: a multicentre cohort study.
Phillip F YangMichael J VenessEdward A CooperRichard FoxRobert I SmeeChristopher LehanePhilip J CroweJulie R HowleStephen R ThompsonPublished in: ANZ journal of surgery (2021)
Combined-modality therapy for metastatic cutaneous squamous cell carcinoma to the axilla is recommended for high-risk patients, although outcomes remain modest. The key period for recurrence is within 2 years following treatment.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- ejection fraction
- newly diagnosed
- clinical trial
- lymph node metastasis
- small cell lung cancer
- sentinel lymph node
- prognostic factors
- locally advanced
- peritoneal dialysis
- randomized controlled trial
- cross sectional
- lymph node
- patient reported outcomes
- study protocol
- radiation therapy
- adipose tissue
- glycemic control
- insulin resistance
- combination therapy
- rectal cancer
- neoadjuvant chemotherapy